| References |
| Formal Name |
(1-(3-hydroxybutyl)-1H-indol-3-yl)(naphthalen-1-yl)-methanone-2,4,5,6,7-d5 |
| Molecular Formula |
C23H16D5NO2 |
| Formula Weight |
348.5 |
| Formulation |
A crystalline solid |
| Purity |
≥99% deuterated product |
| λmax |
218, 246, 315 nm |
| Stability |
1 year |
| Storage |
-20°C |
| Shipping |
Wet ice
in continental US; may vary elsewhere
|
| SMILES |
O=C(C1=CC=CC2=C1C=CC=C2)C3=C([2H])N(CCC(O)C)C4=C([2H])C([2H])=C([2H])C([2H])=C43
|
| Size |
Global Purchasing |
| 100 µg |
|
| 500 µg |
|
| 1 mg |
|
| 5 mg |
|
Description
(±) JWH 073 N-(3-hydroxybutyl) metabolite-d5 contains five deuterium atoms at the 2, 4, 5, 6, and 7 positions. It is intended for use as an internal standard for the quantification of (±) JWH 073 N-(3-hydroxybutyl) metabolite by GC- or LC-mass spectrometry (MS). JWH 073 is a potent cannabimimetic that has been identified as an adulterant in smoking mixtures. JWH 073 N-(3-hydroxybutyl) metabolite is expected to be produced by hepatic metabolism of JWH 073.1,2 The biological actions of this metabolite are unknown.
1
Wintermeyer, A., Möller, I., Thevis, M., et al. In vitro phase I metabolism of the synthetic cannabimimetic JWH-018. Anal Bioanal Chem 398 2141-53 (2010).
2
Zhang, Q., Ma, P., Cole, R.B., et al. Identification of in vitro metabolites of JWH-015, an aminoalkylindole agonist for the peripheral cannabinoid receptor (CB2) by HPLC-MS/MS. Anal Bioanal Chem 386 1345-1355 (2006).
|
